Medicure International Inc
4 drugs in NADAC|0 Generic,4 Brand
Medicure International Inc lists 4 NDCs in the CMS NADAC file (0 generic, 4 brand), at an average NADAC of $7.41 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
4
0G / 4B
Avg Price / Unit
$7.4073
$7.39 – $7.43
Avg 7d Change
-0.04%
Across 2 drugs with changes
7d Activity
of 4 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Pitavastatin Magnesium market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
HMG-CoA Reductase Inhibitor therapeutic class
Review the broader class where Medicure International Inc has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Medicure International Inc make?
Medicure International Inc lists 4 NDCs in the CMS NADAC file — 0 generic and 4 brand products.
What is the average price of Medicure International Inc drugs?
The average NADAC across Medicure International Inc's portfolio is $7.4073 per unit, ranging from $7.3886 to $7.4261.
What types of drugs does Medicure International Inc make?
Medicure International Inc makes drugs across 1 FDA pharmacologic class. The most common by NDC count are HMG-CoA Reductase Inhibitor (4).
Has Medicure International Inc had any drug recalls?
No FDA enforcement recalls are matched to Medicure International Inc in the openFDA feed.
How has Medicure International Inc's pricing changed recently?
Over the past 7 days, 0 Medicure International Inc products rose and 2 fell, with a portfolio-wide average change of -0.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZYPITAMAG 2 MG TABLET Pitavastatin Magnesium | $7.4261 per EA | -0.04% |
ZYPITAMAG 2 MG TABLET Pitavastatin Magnesium | $7.4261 per EA | -0.04% |
ZYPITAMAG 4 MG TABLET Pitavastatin Magnesium | $7.3886 per EA | 0.00% |
ZYPITAMAG 4 MG TABLET Pitavastatin Magnesium | $7.3886 per EA | 0.00% |